Figure 6

Prognostic efficiency prediction of m6A/m5C-lncRNA signatures. (A) Predictive value of RiskScore in clinicopathological subgroups. (B) RiskScore assessments across different clinicopathological groups, including survival status, age, grade, gender, stage, somatic copy number alterations (SCNA) levels, and gastric classification. (C) Sankey diagram visualized the correlation ship of clusters, RiskScore group and survival status. (D) Risk score assessments between different cluster cohorts.